Usha Ramanathan
Volume:
59 - Edition:
1 -
Jan/Feb/Mar -
1991
Persistent reduced solubilization of immune complexes in lepromatous leprosy patients with reactions
V. D. Ramanathan1;
Padmawati Tyagi2;
Usha Ramanathan3;
Kiran Katoch4;
Utpal Sengupta5;
Gopal Ramu6
Volume:
57 - Edition:
3 -
Jul/Aug/Sep -
1989
Effect of chemotherapy on viability of Mycobacterium leprae as determined by ATP content, morphological index and FDA-EB fluorescent staining
Vishwa M. Katoch1;
Kiran Katoch2;
Usha Ramanathan3;
Vishnu D. Sharma4;
Chinappa T. Shivannavar5;
Arun K. Datta6;
Ved P. Bharadwaj7
Volume:
57 - Edition:
2 -
Apr/May/Jun -
1989
Results of a modified WHO regimen in highly bacilliferous BL/LL patients
Kiran Katoch1;
Gopal Ramu2;
Usha Ramanathan3;
Utpal Sengupta4;
Sreevatsa5;
Vishnu D. Sharma6;
Channappa T. Shivannavar7;
Vishwa M. Katoch8
Volume:
57 - Edition:
2 -
Apr/May/Jun -
1989
Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin
Kiran Katoch1;
Usha Ramanathan2;
Mohan Natrajan3;
Ashok K. Bagga4;
A. S. Bhatia5;
R. K. Saxena6;
Gopal Ramu7
Volume:
56 - Edition:
1 -
Jan/Feb/Mar -
1988
Pyrazinamide as a part of combination therapy for BL and LL patients-a preliminary report
Kiran Katoch;
Sreevatsa;
Usha Ramanathan;
Gopal Ramu
Volume:
55 - Edition:
1 -
Jan/Feb/Mar -
1987
Comparison of three regimens containing rifampin for treatment of paucibacillary leprosy patients
Kiran Katoch;
Gopal Ramu;
Usha Ramanathan;
K. V. Desikan